Figure 6. Localization of full-length and truncated ANXA6 constructs with or without ionomycin treatment.
(A) Airyscan 3D projection of U-2 OS cells expressing ANXA6(FL)-mNG with endogenous CD63 and wheat germ agglutinin (WGA) counterstain upon treatment with DMSO or 1 µM ionomycin for 10 min. Green: ANXA6(FL)-mNG; magenta: endogenous CD63 immunofluorescence; blue: WGA CF640R conjugate. Scale bars: 10 µm. (B) Airyscan 3D projection of U-2 OS cells expressing ANXA6(N)-mNG and ANXA6(C)-mSc with WGA counterstain upon treatment with DMSO or 1 µM ionomycin for 10 min. Green: ANXA6(N)-mNG; magenta: ANXA6(C)-mSc; blue: WGA CF640R conjugate. Scale bars: 10 µm. (C) Airyscan 3D projection of U-2 OS cells expressing ANXA6(N)-mNG and ANXA6(C)-mSc with endogenous CD63 upon treatment with DMSO or 1 µM ionomycin for 10 min. Green: ANXA6(N)-mNG; magenta: ANXA6(C)-mSc; blue: endogenous CD63 immunofluorescence. Scale bars: 10 µm.